Drug-Induced Restless Legs Syndrome
- 26 February 2018
- journal article
- review article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 52 (7), 662-672
- https://doi.org/10.1177/1060028018760296
Abstract
Objective: To review the literature on drug-induced restless legs syndrome (DI-RLS). Data Sources: The review included a search for English-language literature from 1966 to December 2017 in the MEDLINE, PubMed, and Ovid databases using the following search terms: restless legs syndrome (RLS), periodic limb movement, adverse effects, and drug-induced. In addition, background articles on the pathophysiology, etiology, and epidemiology of RLS were retrieved. Bibliographies of relevant articles were reviewed for additional citations. Study Selection and Data Extraction: All case reports, case series, and review articles of DI-RLS were identified and analyzed. There were only a small number of controlled clinical trials, and most data were from case reports and case series. Results: Several drugs and drug classes have been implicated in DI-RLS, with antidepressants, antipsychotics, and antiepileptics having the most evidence. In addition, RLS may be linked with a number of disorders or underlying predisposing factors as well. Conclusions: The prevalence of RLS is variable and ranges from 3% to 19% in the general population. There are many predisposing factors to RLS, but an emerging body of evidence suggests that there is an association between numerous drugs and RLS.Keywords
This publication has 71 references indexed in Scilit:
- Restless legs syndrome induced by quetiapine: report of seven cases and review of the literatureInternational Journal of Neuropsychopharmacology, 2013
- Relationship between urinary sodium excretion and pioglitazone‐induced edemaJournal of Diabetes Investigation, 2010
- Association study between antipsychotic‐induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophreniaHuman Psychopharmacology: Clinical and Experimental, 2010
- Gender differences in the association between antidepressant use and restless legs syndromeMovement Disorders, 2009
- Resolution of Pregabalin and Mirtazapine Associated Restless Legs Syndrome by Bupropion in a Patient with Major Depressive DisorderPsychiatry Investigation, 2009
- Factors potentiating the risk of mirtazapine‐associated restless legs syndromeHuman Psychopharmacology: Clinical and Experimental, 2008
- Clozapine-Associated Restless Legs SyndromeJournal of Clinical Psychopharmacology, 2007
- Restless legs syndrome augmentation associated with tramadolSleep Medicine, 2006
- Selective Serotonin Receptor Uptake Inhibitors Can Reduce Restless Legs SymptomsArchives of Internal Medicine, 2000
- Antipsychotic-induced life-threatening ??esophageal dyskinesiaInternational Clinical Psychopharmacology, 1999